Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.
2.
3.

Gene therapy of Parkinson's disease using adeno-associated virus (AAV) vectors.

Ozawa K, Fan DS, Shen Y, Muramatsu S, Fujimoto K, Ikeguchi K, Ogawa M, Urabe M, Kume A, Nakano I.

J Neural Transm Suppl. 2000;(58):181-91. Review.

PMID:
11128607
4.

Recombinant adeno-associated viral vectors bring gene therapy for Parkinson's disease closer to reality.

Muramatsu S, Wang L, Ikeguchi K, Fujimoto K, Nakano I, Ozawa K.

J Neurol. 2002 Sep;249 Suppl 2:II36-40. Review.

PMID:
12375062
5.

Glial cell line-derived neurotrophic factor (GDNF): a drug candidate for the treatment of Parkinson's disease.

Grondin R, Gash DM.

J Neurol. 1998 Nov;245(11 Suppl 3):P35-42. Review.

PMID:
9808338
6.

Neuroprotective and neurorestorative properties of GDNF.

Gash DM, Zhang Z, Gerhardt G.

Ann Neurol. 1998 Sep;44(3 Suppl 1):S121-5. Review.

PMID:
9749583
7.

[AAV vector-mediated gene transfer and its application to the nervous system].

Ozawa K.

Rinsho Shinkeigaku. 2003 Nov;43(11):835-8. Review. Japanese.

PMID:
15152479
8.

Gene transfer techniques for the delivery of GDNF in Parkinson's disease.

Ridet JL, Déglon N, Aebischer P.

Novartis Found Symp. 2000;231:202-15; discussion 215-9, 302-6. Review.

PMID:
11131539
9.

Sustained delivery of GDNF: towards a treatment for Parkinson's disease.

Zurn AD, Widmer HR, Aebischer P.

Brain Res Brain Res Rev. 2001 Oct;36(2-3):222-9. Review.

PMID:
11690619
10.

[Gene therapy for Parkinson's disease: studies in animal models].

Muramatsu S.

Rinsho Shinkeigaku. 2001 Dec;41(12):1157-9. Review. Japanese.

PMID:
12235825
11.

In vivo gene delivery of glial cell line--derived neurotrophic factor for Parkinson's disease.

Kordower JH.

Ann Neurol. 2003;53 Suppl 3:S120-32; discussion S132-4. Review.

PMID:
12666104
12.

Gene transfer for neuroprotection in animal models of Parkinson's disease and amyotrophic lateral sclerosis.

Bohn MC, Connor B, Kozlowski DA, Mohajeri MH.

Novartis Found Symp. 2000;231:70-89; discussion 89-93. Review.

PMID:
11131547
13.

Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease.

Björklund A, Rosenblad C, Winkler C, Kirik D.

Neurobiol Dis. 1997;4(3-4):186-200. Review.

PMID:
9361295
14.

Viral vectors in the treatment of Parkinson's disease.

Latchman DS, Coffin RS.

Mov Disord. 2000 Jan;15(1):9-17. Review.

PMID:
10634236
17.
18.
19.

Glial cell line-derived neurotrophic factor: a novel therapeutic approach to treat motor dysfunction in Parkinson's disease.

Lapchak PA, Gash DM, Jiao S, Miller PJ, Hilt D.

Exp Neurol. 1997 Mar;144(1):29-34. Review.

PMID:
9126148
20.

[Parkinsonism induced by MPTP as an experimental model of Parkinson disease: similarities and differences].

Luquin MR, Obeso JA, Herrero MT, Laguna J, Martínez-Lage JM.

Neurologia. 1991 Oct;6(8):287-94. Review. Spanish.

PMID:
1790005

Supplemental Content

Support Center